| | Mount Vernon Cancer Network Procures
ChemoCare® Chemotherapy ePrescribing
Solution from CIS Oncology Ltd |
| | CIS Oncology Ltd has been awarded the contract to provide Mount Vernon Cancer Network with its chemotherapy eprescribing solution, ChemoCare®. The system will
provide an e-prescribing solution for adult and paediatric, solid tumour and
haematological oncology across the cancer network which consists of three NHS Trusts
within Hertfordshire and South Bedfordshire - Luton & Dunstable Hospital NHS
Foundation Trust, East and North Hertfordshire NHS Trust and West Hertfordshire
Hospitals NHS Trust. The solution will be delivered in collaboration with CSC and will be
hosted in its remote data centre environment.
Dr Peter Ostler, clinical chair for cancer services with the East and North Hertfordshire
NHS Trust, which manages the Mount Vernon Cancer Centre, said:
"The cancer network is looking forward to working with the team at CIS Oncology to put
in place an electronic prescribing system that will benefit all of our patients."
ChemoCare® is the leading electronic chemotherapy prescribing software in use across
the NHS within over 60 hospitals. The final selection was made because of the solution’s
unique ability to meet both the National OBS for chemotherapy prescribing; the specific
local functional needs of the network’s clinical chemotherapy services and infrastructure
challenges of the network’s IT infrastructure.
The overriding strategic objectives of the network included:
To improve patient care outcomes by treating patients effectively, efficiently and safely.
To ensure a high quality patient experience by improving access to appropriate resources and offering patient choice.
To ensure capture of data and information to enable access and report on
activity.
Tony Pegg, Chief Executive Officer of CIS Oncology said:
I am delighted that Mount Vernon Cancer Network has chosen ChemoCare® for their
electronic chemotherapy prescribing system. This award demonstrates our ability to
work in partnership with CSC to deliver the unique requirements of the Cancer Network.
We are looking forward to working together with CSC and the Network on this
implementation.”
Neil Spencer, Senior Executive for CSC Healthcare for this project said: “This award
exemplifies CSC‘s commitment to delivering patient centred healthcare solutions. We
believe the arrangement enables both ourselves and CIS Healthcare to come together
and focus on our core business strengths for the improvement of healthcare services
within the cancer network.”
- Ends -
NOTES TO EDITORS:
For press enquiries, please contact:
Valerie Lee
Sales Director
CIS Oncology Ltd
Unit 4 Channel Wharf
Old Channel Road
Belfast BT3 9DE
Tel: +44 (0)2890 735950
Mobile: 07717 794340
Email: valerie.lee@cis-healthcare.com
Joanne Davis
CSC UK
External Communications Manager
Tel: +44(0)1252 536737
Mobile: +44 7799476532
Email: jdavis62@csc.com
About CIS Oncology:
CIS Oncology is a leading specialist software company which provides software products and support specifically relating
to the complex needs of health professionals within the field of chemotherapy oncology healthcare market.
CIS Oncology is part of the larger CIS Healthcare Ltd organisation. CIS Healthcare Ltd is a growing provider of Healthcare IT systems to the NHS and internationally. Today the company has a turnover in excess of £4m with offices in
London, Aalborg, Belfast, Hamburg, Cwmbran, Reykjavik and Tilburg and comprises four businesses operating in four sectors of specialty which are:
CIS Oncology: The leading supplier of chemotherapy prescribing and management systems in the UK and currently
implemented in over 60 hospitals with over fifteen years experience in successfully delivering solutions to the NHS;
Theriak Medication Management (TMM): State-of-the-art drug prescribing, dispensing and bed side verification
software; built to support the complete closed loop of medication management in the hospital. In excess of 1000
users across Holland, Iceland, Sweden, Denmark and Germany;
CIS Orion Imaging: Diabetic Retinopathy screening system in use in over 35 screening programs in England:
CIS GmbH, CYPRO: Chemotherapy drug preparation management system with over 500 users in cancer treatment
centres, primarily in Germany.
About CSC:
CSC is a global leader in providing technology-enabled solutions and services through its lines of business which include
Business Solutions & Services and Global Outsourcing Services and across all major industry sectors. CSC’s advanced
capabilities include systems design and integration, information technology and business process outsourcing
applications software development, Web and application hosting, mission support and management consulting.
Headquartered in Falls Church, Va., CSC has approximately 92,000 employees and reported revenue of $17.1 billion for
the 12 months ended Jan 2, 2009. For more information, visit the company’s Web site at www.csc.com.
About Mount Vernon Cancer Network:
The Mount Vernon Cancer Network links clinicians and others that provide care for cancer patients across a large area that includes Hertfordshire, Bedfordshire, North West London, South Buckinghamshire and East Berkshire. It serves a
population of around 2 million, approximately 1.3million of whom live in Hertfordshire and South Bedfordshire. It links
together one cancer centre, 15 district general hospitals, 16 Primary Care trusts, a large number of hospices and other specialist care providers. The aim of the Cancer Network is to ensure that high quality services are provided for all patients.
|